Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2025-12-24 @ 6:43 PM
NCT ID:
NCT04487457
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old
* Patients treated with immune checkpoint inhibitor alone or in combination with chemotherapy in 1st or 2nd line
* Patient with locally advanced or metastatic Non-Small-Cell Lung Cancer, or bladder cancer or Ear Nose Throat cancer
* Maximum delay of 2 months between ICI and chemotherapy
Exclusion Criteria:
* Symptomatic brain metastases
* Corticotherapy \> 10 mg/day
* Active auto-immune disease
* Oncogenic addiction
* Data processing objection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04487457
Study Brief:
Protocol Section:
NCT04487457